Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

YM17E

Known as: YM 17E 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
We conducted a single and repeat oral dose study of YM17E, a novel inhibitor of acyl coenzyme A (CoA): cholesterol… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1998
1998
The relationship between bioavailability and the serum cholesterol-lowering effect of YM17E, an ACAT inhibitor was investigated… Expand
Is this relevant?
1997
1997
YM17E (1,3-bis[[1-cycloheptyl-3-(p-dimethylaminophenyl)ureido]methyl]ben zene dihydrochloride) was found to be a potent inhibitor… Expand
Is this relevant?
1996
1996
Because YM17E (1,3-bis[[1-cycloheptyl-3-(p-dimethylaminophenyl) ureido]methyl]benzene dihydrochloride) inhibits acyl coenzyme A… Expand
Is this relevant?
1994
1994
1. We have investigated the disposition and metabolism of YM17E after intravenous and oral administration in the rat and dog. 2… Expand
Is this relevant?
1993
1993
We describe a reversed-phase high-performance liquid chromatographic method for the determination in plasma of YM17E (I), an… Expand
Is this relevant?
1993
1993
The metabolism of 1,3-bis[[1-cycloheptyl-3-(p-dimethylamino- phenyl)ureido]methyl]benzene dihydrochloride (YM17E) in rat liver… Expand
Is this relevant?